Efficacy/Safety of CPI-613 in Combination With HD Cyt. and Mito. vs HD Cyt. and Mito. in Older Patients With R/R AML
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
60 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Border Medical Oncology Research Unit
Albury, New South Wales, Australia
- Gosford Hospital
Gosford, New South Wales, Australia
- Calvary Mater Newcastle Hospital
Waratah, New South Wales, Australia
- Royal Perth Hospital
Perth, Western Australia, Australia
- Universitätsklinik Für Innere Medizin
Graz, Austria
- Paracelsus Medical University
Salzburg, Austria
- Hanuschkrankenhaus Der Wgkk
Vienna, Austria
- Algemeen Ziekenhuis Sint-Jan
Bruges, Belgium
- Clinique Universitaire St Luc
Brussels, Belgium
- Un Gent
Ghent, Belgium
- Centre Hospitalier de Versailles - Hôpital André Mignot
Le Chesnay, Yvelines, France
- Chu Amiens
Amiens, France
- Service D'Hématologie Clinique, Hôpital Avicenne-Aphp-Université Paris
Bobigny, France
- Chu de Caen
Caen, France
- Centre Hospitalier Universitaire Grenoble Hopital Michalon
Grenoble, France
- Chu la Conecption
Marseille, France
- Chu de Nice
Nice, France
- Hopital Saint Louis
Paris, France
- Centre Hospitalier Lyon Sud
Pierre-Bénite, France
- Klinikum Frankfurt Hoechst
Frankfurt, Germany
- Universitatsklinikumuksh Kiel
Kiel, Germany
- Universitatsklinikum Marburg
Marburg, Germany
- Robert-Bosch- Krankenhaus
Stuttgart, Germany
- Zespół Szpitali Miejskich W Chorzowie
Chorzów, Poland
- Uniwersyteckie Centrum Kliniczne Klinika Hematologii I Transplantologii
Gdansk, Poland
- Katedra I Klinika Hematologii
Wroclaw, Poland
- Asan Medical Center
Seoul, South Korea
- Samsung Medical Center
Seoul, South Korea
- Seoul National University Hospital
Seoul, South Korea
- Severance Hospital
Seoul, South Korea
- Institut Catala D'Oncologia (ico) - Hospital Universitari Germans Trias I Pujol
Badalona, Spain
- Hospital Vall D'Hebron
Barcelona, Spain
- Md Anderson Cancer Center
Madrid, Spain
- Hospital Universitario Virgen de la Victoria
Málaga, Spain
- Hospital Son Espases
Palma de Mallorca, Spain
- Hospital Clínico Universitario de Salamanca
Salamanca, Spain
- Hospital U. P. la Fe
Valencia, Spain
- Honor Health Research Institute
Scottsdale, Arizona, United States
- Chao Family Comprehensive Cancer Center (university of California Irvine)
Orange, California, United States
- California Pacific Medical Center
San Francisco, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 12 Nov 2018
- Primary completion
- 25 Oct 2021
- Completion
- 19 Jan 2022
- Last update posted
- 8 Feb 2023
- Registered enrollment
- 200
- Registry id
- NCT03504410
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.